TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Conditions: Breast Cancer Interventions: Drug: vepdegestrant; Drug: Samuraciclib Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc.; Carrick Therapeutics Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials